Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-19-000136
Filing Date
2019-11-21
Accepted
2019-11-21 18:40:25
Documents
1
Period of Report
2019-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4023
  Complete submission text file 0000874015-19-000136.txt   5472
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 191238325